January 2025
42 articles-
Jan 31 · 08:56Biotechnology Daily
J&J jettisons several programs, ends seltorexant work in Alzheimer's disease
-
Jan 31 · 08:53Biotechnology Daily
Chinese insulin maker says its GLP-1 beat Ozempic at lowering blood sugar, body weight in phase 2
-
Jan 31 · 08:52Bio Business News
Ceribell CEO Jane Chao explains why now was the time for its upsized IPO
-
Jan 31 · 08:49Bio Business News
New cell therapy biotech emerges with $17M, thymus-targeting therapies
-
Jan 29 · 20:36Biotechnology Daily
Notable Labs files for bankruptcy, ending ambitions for Boehringer cancer drug
-
Jan 29 · 20:34Biotechnology Daily
Topas says celiac candidate shines in phase 2a but keeps data under wraps for now
-
Jan 29 · 20:32Bio Business News
Pfizer taps Triana to discover molecular glues for cancer and beyond in deal potentially worth $1.5B
-
Jan 29 · 20:31Bio Business News
J&J, with adult approval in sight, posts adolescent myasthenia gravis data on $6.5B FcRn blocker
-
Jan 28 · 20:45Biotechnology Daily
Jasper dials up dose after complete responses come and go quickly in hives trial
-
Jan 28 · 20:45Biotechnology Daily
Novartis channels Gargamel, terminating midphase SMURF1 trial
-
Jan 28 · 20:44Bio Business News
Transgene's viral cancer vaccine flunks midphase test—but subgroup signal spurs ongoing analysis
-
Jan 28 · 20:43Bio Business News
Lilly picks UK for first European Gateway Lab as part of $364M investment plan
-
Jan 27 · 20:22Biotechnology Daily
Capricor cell therapy improves cardiac and upper limb function in phase 2 Duchenne muscular dystrophy victory lap
-
Jan 27 · 20:17Biotechnology Daily
After axing its sole clinical prospect last year, Alaunos cuts ties with Precigen
-
Jan 27 · 20:16Bio Business News
Bruker spools up spatial biology division from NanoString, Canopy assets
-
Jan 27 · 20:15Bio Business News
Turnstone lays off 60% of staff, shakes up C-suite to keep cancer cell therapy on track
-
Jan 26 · 22:15Biotechnology Daily
Deep learning AI model scans 'dark matter' of genomic data to find 70,000 never-before-seen RNA viruses
-
Jan 26 · 22:12Biotechnology Daily
Novo Holdings-backed Booster takes off with protein degraders aimed at neurodegeneration
-
Jan 26 · 22:04Bio Business News
Gritstone files for bankruptcy in hope of keeping cancer vaccine R&D afloat
-
Jan 26 · 22:02Bio Business News
Glooko collects $100M, plus a new CEO, to boost its diabetes platform
-
Jan 2 · 20:51Biotechnology Daily
Orion to use Aitia's 'digital twins' to identity potential new cancer drugs
-
Jan 2 · 20:48Biotechnology Daily
Windtree's cardiogenic shock med raises blood pressure in latest phase 2 win
-
Jan 2 · 20:45Biotechnology Daily
Merck's Keytruda-LAG-3 combo fails to tame tough colorectal cancer in phase 3
-
Jan 2 · 20:43Biotechnology Daily
New PicnicHealth service brings observational clinical trial research to the virtual world